SCHEMBL684634

SCHEMBL684634

O=C(N/N=C/c1ccccc1O)c1ccc(Br)cc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM1A O60341 3/20 1.00
MAOA P21397 1/20 0.78
MAOB P27338 1/20 0.78
RAB9A P51151 5/20 0.70
NPC1 O15118 4/20 0.70
HTT P42858 2/20 0.70
L3MBTL1 Q9Y468 2/20 0.70
MAPT P10636 3/20 0.69
SMN1; SMN2 Q16637 2/20 0.69
MAPK1 P28482 2/20 0.69
CA12 O43570 1/20 0.69
CA1 P00915 1/20 0.69
CA2 P00918 1/20 0.69
CA9 Q16790 1/20 0.69
KMT2A Q03164 7/20 0.67
MEN1 O00255 6/20 0.67
KDM4E B2RXH2 3/20 0.67
LMNA P02545 2/20 0.67
PSMD14 O00487 1/20 0.67
POLB P06746 1/20 0.67

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6568266 1.00 KDM1A (1.00) KDM1AMAOAMAOBRAB9ANPC1
SCHEMBL2842569 1.00 KDM1A (1.00) KDM1AMAOAMAOBRAB9ANPC1
SCHEMBL15853740 0.90 KDM1A (0.81) KDM1AMAOAMAOBRAB9ANPC1
SCHEMBL21145712 0.89 KDM1A (0.80) KDM1AMAOAMAOBRAB9AHTT
SCHEMBL13362126 0.89 KDM1A (0.80) KDM1AMAOAMAOBRAB9AHTT
SCHEMBL19283316 0.88 KDM1A (1.00) KDM1AMAOAMAOBRAB9ANPC1
SCHEMBL15176803 0.88 KDM1A (1.00) KDM1AMAOAMAOBRAB9ANPC1
SCHEMBL14712666 0.88 KDM1A (1.00) KDM1AMAOAMAOBRAB9ANPC1
Salicylaldehyde Benzoyl Hydrazone SCHEMBL414978 0.88 KDM1A (0.82) KDM1AMAOAMAOBRAB9ANPC1
Salicylaldehyde Benzoyl Hydrazone SCHEMBL414977 0.88 KDM1A (0.82) KDM1AMAOAMAOBRAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2744330-B1 SUBSTITUTED (E)-N'-(1-PHENYLETHYLIDENE) BENZOHYDRAZIDE ANALOGS AS HISTONE DEMETHYLASE INHIITORS UNIV UTAH RES FOUND (US) 2020-07-15 EP disclosed
EP-3010915-B1 SUBSTITUTED (3-(5-CHLORO-2-HYDROXYPHENYL)-1-BENZOYL-1H-PYRAZOLE COMPOUNDS AS HISTONE DEMETHYLASE INHIBITORS UNIV UTAH RES FOUND (US) 2019-05-08 EP disclosed
US-9642857-B2 Substituted (E)-N′-(1-phenylethylidene)benzohydrazide analogs as histone demethylase inhibitors UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) 2017-05-09 US disclosed
US-9642857-B2 Substituted (E)-N′-(1-phenylethylidene)benzohydrazide analogs as histone demethylase inhibitors UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) 2017-05-09 US disclosed
US-9555024-B2 Substituted (E)-N′-(1-phenylethylidene)benzohydrazide analogs as histone demethylase inhibitors UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) 2017-01-31 US disclosed
US-9555024-B2 Substituted (E)-N′-(1-phenylethylidene)benzohydrazide analogs as histone demethylase inhibitors UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) 2017-01-31 US disclosed
US-20160120875-A1 SUBSTITUTED (E)-N'-(1-PHENYLETHYLIDENE)BENZOHYDRAZIDE ANALOGS AS HISTONE DEMETHYLASE INHIBITORS UNIV UTAH RES FOUND (US) 2016-05-05 US disclosed
US-20160120875-A1 SUBSTITUTED (E)-N'-(1-PHENYLETHYLIDENE)BENZOHYDRAZIDE ANALOGS AS HISTONE DEMETHYLASE INHIBITORS UNIV UTAH RES FOUND (US) 2016-05-05 US disclosed
US-9266838-B2 Substituted (E)-N′-(1-phenylethylidene)benzohydrazide analogs as histone demethylase inhibitors UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) 2016-02-23 US disclosed
US-9266838-B2 Substituted (E)-N′-(1-phenylethylidene)benzohydrazide analogs as histone demethylase inhibitors UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) 2016-02-23 US disclosed
US-20140163017-A1 SUBSTITUTED (E)-N'-(1-PHENYLETHYLIDENE)BENZOHYDRAZIDE ANALOGS AS HISTONE DEMETHYLASE INHIBITORS UNIVERSITY OF UTAH (US) 2014-06-12 US disclosed
WO-2013025805-A1 SUBSTITUTED (E)-N'-(1-PHENYLETHYLIDENE) BENZOHYDRAZIDE ANALOGS AS HISTONE DEMETHYLASE INHIITORS UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) 2013-02-21 WO disclosed
US-20120010075-A1 SYNERGISTIC FUNGICIDAL COMPOSITIONS INCLUDING HYDRAZONE DERIVATIVES AND COPPER DOW AGROSCIENCES LLC (US) 2012-01-12 US disclosed
US-20120010075-A1 SYNERGISTIC FUNGICIDAL COMPOSITIONS INCLUDING HYDRAZONE DERIVATIVES AND COPPER DOW AGROSCIENCES LLC (US) 2012-01-12 US disclosed
US-20100130450-A1 Methods of Treating Fungal Infections NORTHEASTERN UNIVERSITY (US) 2010-05-27 US disclosed
US-20100130450-A1 Methods of Treating Fungal Infections NORTHEASTERN UNIVERSITY (US) 2010-05-27 US disclosed
US-20100130450-A1 Methods of Treating Fungal Infections NORTHEASTERN UNIVERSITY (US) 2010-05-27 US disclosed
EP-2146702-A2 METHODS OF TREATING FUNGAL INFECTIONS NorthEastern University (US) 2010-01-27 EP disclosed
WO-2008137128-A2 METHODS OF TREATING FUNGAL INFECTIONS NORTHEASTERN UNIVERSITY (US) 2008-11-13 WO disclosed
WO-2008137128-A2 METHODS OF TREATING FUNGAL INFECTIONS NORTHEASTERN UNIVERSITY (US) 2008-11-13 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120010075-A1 SYNERGISTIC FUNGICIDAL COMPOSITIONS INCLUDING HYDRAZONE DERIVATIVES AND COPPER SOD1, CYP51A1, SOD3 KDM1A 484/4885MAOA 509/4885MAOB 811/4885
US-20100130450-A1 Methods of Treating Fungal Infections ERG28, DPM1, COXFA4L2 KDM1A 3517/4885MAOA 726/4885MAOB 819/4885
US-20140163017-A1 SUBSTITUTED (E)-N'-(1-PHENYLETHYLIDENE)BENZOHYDRAZIDE ANALOGS AS HISTONE DEMETHYLASE INHIBITORS KDM1B, KDM1A, DOT1L KDM1A 2/4885MAOA 120/4885MAOB 121/4885
US-20160120875-A1 SUBSTITUTED (E)-N'-(1-PHENYLETHYLIDENE)BENZOHYDRAZIDE ANALOGS AS HISTONE DEMETHYLASE INHIBITORS DOT1L, NSD1, KDM1B KDM1A 7/4885MAOA 1158/4885MAOB 1100/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.